MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with A

Alpelisib

Alpelisib 50mg tablets

No stability information

Stability notes for Alpelisib 50mg tablets

There are no stability notes for this medicine.

Supplier

Piqray 50mg tablets (Novartis Pharmaceuticals UK Ltd)

Alpelisib 50mg tablets and Alpelisib 200mg tablets

No stability information

Stability notes for Alpelisib 50mg tablets and Alpelisib 200mg tablets

There are no stability notes for this medicine.

Supplier

Piqray 50mg tablets and Piqray 200mg tablets (Novartis Pharmaceuticals UK Ltd)

Alpelisib 150mg tablets

No stability information

Stability notes for Alpelisib 150mg tablets

There are no stability notes for this medicine.

Supplier

Piqray 150mg tablets (Novartis Pharmaceuticals UK Ltd)

Alpelisib 200mg tablets

No stability information

Stability notes for Alpelisib 200mg tablets

There are no stability notes for this medicine.

Supplier

Piqray 200mg tablets (Novartis Pharmaceuticals UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.